Federica Balzarini
Overview
Explore the profile of Federica Balzarini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Traverso P, Carfi A, Bulanti A, Fabbi M, Giasotto V, Mattiauda M, et al.
Urol Oncol
. 2024 Nov;
43(3):192.e11-192.e19.
PMID: 39537441
Objective: The Contact Surface Area (CSA) is a predictor for peri-operative parameters and represents the contact area between the tumor and the organ. A precise method for calculating CSA is...
2.
Sossen B, Richards A, Heinsohn T, Frascella B, Balzarini F, Oradini-Alacreu A, et al.
Lancet Respir Med
. 2023 Mar;
11(4):367-379.
PMID: 36966795
Stages of tuberculosis disease can be delineated by radiology, microbiology, and symptoms, but transitions between these stages remain unclear. In a systematic review and meta-analysis of studies of individuals with...
3.
Richards A, Sossen B, Emery J, Horton K, Heinsohn T, Frascella B, et al.
Lancet Glob Health
. 2023 Mar;
11(5):e684-e692.
PMID: 36966785
Background: Prevalence surveys show a substantial burden of subclinical (asymptomatic but infectious) tuberculosis, from which individuals can progress, regress, or even persist in a chronic disease state. We aimed to...
4.
Malinaric R, Mantica G, Martini M, Balzarini F, Mariano F, Marchi G, et al.
Int J Environ Res Public Health
. 2023 Mar;
20(5).
PMID: 36901138
Extracorporeal shockwave lithotripsy (ESWL) is the only non-invasive treatment for kidney stones. It does not require an operating room, anesthesia, or hospital stay. Its role evolved over the years and...
5.
Paladini A, Cochetti G, Colau A, Mouton M, Ciarletti S, Felici G, et al.
Curr Oncol
. 2022 Oct;
29(10):6826-6833.
PMID: 36290815
Increased diagnoses of silent prostate cancer (PCa) have led to overtreatment and consequent functional side effects. Focal therapy (FT) applies energy to a prostatic index lesion treating only the clinically...
6.
Malinaric R, Balzarini F, Granelli G, Ferrari A, Trani G, Ambrosini F, et al.
Front Oncol
. 2022 Oct;
12:976947.
PMID: 36248976
Breast cancer is one of the most important causes of premature mortality in women worldwide. Around 12% of breast cancer patients will develop metastatic disease, a stage associated with poor...
7.
Malinaric R, Mantica G, Balzarini F, Terrone C, Maffezzini M
Arch Ital Urol Androl
. 2022 Jul;
94(2):144-149.
PMID: 35775336
Introduction And Objectives: Radical cystectomy (RC) continues to be standard of care for muscle-invasive bladder cancer and recurrent or refractory nonmuscle invasive bladder cancer. Unfortunately, it has high rates of...
8.
Ricco M, Ranzieri S, Peruzzi S, Valente M, Marchesi F, Bragazzi N, et al.
Acta Biomed
. 2022 May;
93(2):e2022036.
PMID: 35546034
Materials And Methods: We reported our meta-analysis according to the PRISMA statement. We searched Pubmed, Embase, and pre-print archive medRxiv.og for eligible studies published up to November 5th, 2020. Raw...
9.
Ricco M, Ranzieri S, Balzarini F, Vezzosi L, Marchesi F, Valente M, et al.
Acta Biomed
. 2022 May;
93(2):e2022042.
PMID: 35546029
Background And Aim: A growing number of European Countries have adopted front-of-pack nutrition labels (FPNL) in order to assist costumers' alimentary choices, and particularly Nutri-Score. While its acceptance in Italy...
10.
Mantica G, Balzarini F, Chierigo F, Keller E, Talso M, Emiliani E, et al.
Minerva Urol Nephrol
. 2022 Feb;
74(2):169-177.
PMID: 35147384
Introduction: The aim of this systematic review and meta-analysis was to provide an updated comparison between the currently available minimally invasive approaches (PCNL, laparoscopic [LP] and robotic pyelolithotomy [RP]) for...